(Stroke. 1999;30:2562.)
© 1999 American Heart Association, Inc.
Original Contributions |
From the Departments of Epidemiology and Biostatistics (I.C.D.W., B.A.I.V., M.L.B., J.M.A., A.H., D.E.G., F.C.M.W.), Erasmus University Medical School, Rotterdam; Julius Center for Patient Oriented Research, University Medical Center Utrecht (M.L.B., D.E.G.); and Drug Safety Unit, Inspectorate for Health Care, The Hague (B.A.I.V.) (Netherlands).
Correspondence to Dr J.C.M. Witteman, Department of Epidemiology and Biostatistics, Erasmus University Medical School Rotterdam, PO Box 1738, 3000 DR, Rotterdam, Netherlands. E-mail witteman{at}epib.fgg.eur.nl
Background and PurposeObservational data suggest that hormone replacement therapy (HRT) reduces morbidity and mortality from cardiovascular disease in healthy postmenopausal women. The mechanisms underlying this protection are not entirely clear but may include inhibition of the atherosclerotic process.
MethodsWe studied the association between ever use of HRT and intima-media thickness (IMT) of the common carotid artery in 1103 naturally menopausal women, aged 55 to 80 years, in the Rotterdam Study, a community-based cohort study in a suburban area of Rotterdam, Netherlands. Mean and maximum IMT of the common carotid artery were measured noninvasively with B-mode ultrasound.
ResultsEver use of HRT for
1 year was associated with a
decreased mean and maximum IMT compared with never users (mean IMT,
0.719 mm [SE 0.01] versus 0.742 mm [SE 0.004],
P=0.03; maximum IMT, 0.952 mm [SE 0.015] versus
0.983 mm [SE 0.006], P=0.04), after adjustment
for age, smoking, educational level, systolic blood pressure,
and body mass index. No association was found for use <1 year (mean
IMT, 0.739 mm [SE 0.013] versus 0.742 mm [SE 0.004],
P=0.69; maximum IMT, 0.990 mm [SE 0.019] versus
0.983 mm [SE 0.006], P=0.75). Additional
adjustment for diabetes, frequency of visits to healthcare facilities,
or total and HDL cholesterol did not change these
results.
ConclusionsThe findings of this population-based study show that ever use of HRT is associated with a decreased IMT in the common carotid artery in elderly women.
Key Words: atherosclerosis carotid arteries estrogen hormone replacement therapy intima-media thickness
This article has been cited by other articles:
![]() |
M. Diamant, H. J. Lamb, M. A. van de Ree, E. L. Endert, Y. Groeneveld, M. L. Bots, P. J. Kostense, and J. K. Radder The Association between Abdominal Visceral Fat and Carotid Stiffness Is Mediated by Circulating Inflammatory Markers in Uncomplicated Type 2 Diabetes J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1495 - 1501. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Orio Jr., S. Palomba, T. Cascella, B. De Simone, S. Di Biase, T. Russo, D. Labella, F. Zullo, G. Lombardi, and A. Colao Early Impairment of Endothelial Structure and Function in Young Normal-Weight Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4588 - 4593. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Simon, P. Boutouyrie, J.M. Simon, B. Laloux, C. Tournigand, A.I. Tropeano, S. Laurent, and P. Jaillon Influence of Tamoxifen on Carotid Intima-Media Thickness in Postmenopausal Women Circulation, December 3, 2002; 106(23): 2925 - 2929. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. in 't Veld, L. J. Launer, M. M. B. Breteler, A. Hofman, and B. H. Ch. Stricker Pharmacologic Agents Associated with a Preventive Effect on Alzheimer's Disease: A Review of the Epidemiologic Evidence Epidemiol. Rev., December 1, 2002; 24(2): 248 - 268. [Full Text] [PDF] |
||||
![]() |
K.-S. Cheng, D. P. Mikhailidis, G. Hamilton, and A. M. Seifalian A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors Cardiovasc Res, June 1, 2002; 54(3): 528 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Stork, K. Baumann, C. von Schacky, and P. Angerer The effect of 17{beta}-estradiol on MCP-1 serum levels in postmenopausal women Cardiovasc Res, February 15, 2002; 53(3): 642 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. FRIEDLANDER The physiology, medical management and oral implications of menopause J Am Dent Assoc, January 1, 2002; 133(1): 73 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. N. Hodis, W. J. Mack, R. A. Lobo, D. Shoupe, A. Sevanian, P. R. Mahrer, R. H. Selzer, C.-r. Liu, C.-h. Liu, S. P. Azen, et al. Estrogen in the Prevention of Atherosclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial Ann Intern Med, December 4, 2001; 135(11): 939 - 953. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. FRIEDLANDER and L. ALTMAN Carotid artery atheromas in postmenopausal women: Their prevalence on panoramic radiographs and their relationship to atherogenic risk factors J Am Dent Assoc, August 1, 2001; 132(8): 1130 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Edmunds, M. Landray, and G. Y.H. Lip Hormone Replacement Therapy and Intima-Media Thickness of the Common Carotid Artery: The Rotterdam Study Stroke, September 1, 2000; 31 (9): i - 2278. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |